Zobrazeno 1 - 10
of 219
pro vyhledávání: '"Jiachen Xu"'
Autor:
Zhenlin Yang, He Tian, Xiaowei Chen, Bozhao Li, Guangyu Bai, Qingyuan Cai, Jiachen Xu, Wei Guo, Shuaibo Wang, Yue Peng, Qing Liang, Liyan Xue, Shugeng Gao
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-18 (2024)
Abstract Neoadjuvant immunochemotherapy (nICT) has dramatically changed the treatment landscape of operable esophageal squamous cell carcinoma (ESCC), but factors influencing tumor response to nICT are not well understood. Here, using single-cell RNA
Externí odkaz:
https://doaj.org/article/03862393100741308e57f30628932c63
Publikováno v:
Pneumonia, Vol 16, Iss 1, Pp 1-4 (2024)
Abstract Background Pneumonic-type lung adenocarcinoma (P-ADC) is a rare and challenging subtype of primary lung cancer that can be difficult to distinguish from pneumonia based on radiological images. Furthermore, no drugs are currently available th
Externí odkaz:
https://doaj.org/article/a20eb52bb1514b2b9f01dd60b9e97ece
Autor:
Weiqi Li, Xinbao Zhao, Jiachen Xu, Hao Liu, Yuan Cheng, Quanzhao Yue, Wanshun Xia, Yuefeng Gu, Ze Zhang
Publikováno v:
Journal of Materials Research and Technology, Vol 29, Iss , Pp 1453-1466 (2024)
The isothermal oxidation behavior of fourth-generation nickel-based single crystal superalloys with 2-4 wt% Mo content were studied at 900 °C and 1100 °C.At 1100 °C, the oxide layer can be divided into three layers, the outermost layer is Ni–Co
Externí odkaz:
https://doaj.org/article/1050e3118cc74dae980c13c3f7ea691f
Autor:
Jinfu Qian, Qinyan Wang, Jiachen Xu, Shiqi Liang, Qingsong Zheng, Xiaocheng Guo, Wu Luo, Weijian Huang, Xiaohong Long, Julian Min, Yi Wang, Gaojun Wu, Guang Liang
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 8, Pp n/a-n/a (2024)
Abstract Background Chronic inflammation contributes to the progression of isoproterenol (ISO)‐induced heart failure (HF). Caspase‐associated recruitment domain (CARD) families are crucial proteins for initiation of inflammation in innate immunit
Externí odkaz:
https://doaj.org/article/66fdcc9941db4b60a02b485ff6e3fd6b
Publikováno v:
Frontiers in Energy Research, Vol 12 (2024)
In today’s digital age, multi-energy systems (MES) have become an indispensable part of the social infrastructure, providing people with diversified energy support such as electricity, gas, water and so on. However, with the increasing popularity a
Externí odkaz:
https://doaj.org/article/fedf9098e6f24976b51db755b06f7c10
Autor:
Jiefei Han, Yiting Dong, Xiuli Zhu, Alexandre Reuben, Jianjun Zhang, Jiachen Xu, Hua Bai, Jianchun Duan, Rui Wan, Jie Zhao, Jing Bai, Xuefeng Xia, Xin Yi, Chao Cheng, Jie Wang, Zhijie Wang
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-15 (2024)
Abstract Despite the central role of human leukocyte antigen class I (HLA-I) in tumor neoantigen presentation, quantitative determination of presentation capacity remains elusive. Based on a pooled pan-cancer genomic dataset of 885 patients treated w
Externí odkaz:
https://doaj.org/article/d81e01705721423fa5028798af08893d
Autor:
Jiachen Xu, Yundi Zhang, Man Li, Zhuo Shao, Yiting Dong, Qingqing Li, Hua Bai, Jianchun Duan, Jia Zhong, Rui Wan, Jing Bai, Xin Yi, Fuchou Tang, Jie Wang, Zhijie Wang
Publikováno v:
EBioMedicine, Vol 102, Iss , Pp 105092- (2024)
Summary: Background: The high heterogeneity of tumour and the complexity of tumour microenvironment (TME) greatly impacted the tumour development and the prognosis of cancer in the era of immunotherapy. In this study, we aimed to portray the single c
Externí odkaz:
https://doaj.org/article/40ce7b716cb54a2cb4789c03a693071f
Autor:
Zhenlin Yang, Bolun Zhou, Wei Guo, Yue Peng, He Tian, Jiachen Xu, Shuaibo Wang, Xiaowei Chen, Bin Hu, Chengming Liu, Zhijie Wang, Chunxiang Li, Shugeng Gao, Jie He
Publikováno v:
EBioMedicine, Vol 101, Iss , Pp 105019- (2024)
Summary: Background: In recent years, a growing number of patients with multiple primary lung cancer (MPLC) are being diagnosed, and a subset of these patients is found to have a large number of lesions at the time of diagnosis, which are referred to
Externí odkaz:
https://doaj.org/article/d7127329658f4ca6a9f4c0fae75ce7aa
Publikováno v:
Separations, Vol 11, Iss 7, p 213 (2024)
Futibatinib is an excellent fibroblast growth factor receptor 1–4 (FGFR 1–4) inhibitor that exhibits selective anti-tumor activeness against FGFR-deregulated tumors. A new high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/M
Externí odkaz:
https://doaj.org/article/00078624fbc9485196c744c9c7a69696
Autor:
Chao Wang, Kailun Fei, Lihui Liu, Jianchun Duan, Zhijie Wang, Sini Li, Jiachen Xu, Xue Zhang, Yanhua Tian, Yan Qu, Hua Bai, Jie Wang
Publikováno v:
Thoracic Cancer, Vol 14, Iss 19, Pp 1843-1856 (2023)
Abstract Background Osimertinib is the first‐line treatment for patients with epidermal growth factor receptor (EGFR) mutations, but the treatment options after drug resistance are limited. Previous studies have suggested that EGFR is in an immunos
Externí odkaz:
https://doaj.org/article/14f018e3294940ccb51db39c768c675f